John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$332M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$309M |
| 3 |
Nike
NKE
|
+$252M |
| 4 |
NVIDIA
NVDA
|
+$209M |
| 5 |
Target
TGT
|
+$202M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$238M |
| 2 |
PCGU
PG&E Corporation
PCGU
|
+$218M |
| 3 |
ConocoPhillips
COP
|
+$185M |
| 4 |
Amazon
AMZN
|
+$165M |
| 5 |
Cigna
CI
|
+$159M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.77% |
| 2 | Healthcare | 13.86% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Industrials | 11.24% |
| 5 | Financials | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Kodiak Gas Services
KGS
$5.98B
| $520K | ﹤0.01% |
+32,000
| New | +$511K |
|
2277
The ONE Group
STKS
$52.1M
| $518K | ﹤0.01% |
70,753
+6,938
| +11% | +$52.7K |
|
2278
Kratos Defense & Security Solutions
KTOS
$9.96B
| $516K | ﹤0.01% |
36,000
+496
| +1% | +$6.72K |
|
|
JBIO
2279
Jade Biosciences
JBIO
$1.36B
| $515K | ﹤0.01% |
857
+528
| +160% | +$338K |
|
|
INVX
2280
Innovex International
INVX
$2B
| $515K | ﹤0.01% |
+22,110
| New | +$563K |
|
2281
Bank of Marin Bancorp
BMRC
$439M
| $514K | ﹤0.01% |
29,092
-45,074
| -61% | -$818K |
|
|
LSEA
2282
DELISTED
Landsea Homes
LSEA
| $514K | ﹤0.01% |
54,983
+20,790
| +61% | +$145K |
|
2283
Zymeworks
ZYME
$2.06B
| $511K | ﹤0.01% |
59,200
+15,600
| +36% | +$140K |
|
2284
Itaú Unibanco
ITUB
$82.9B
| $511K | ﹤0.01% |
98,118
| – | – |
|
|
IMOS
2285
ChipMOS TECHNOLOGIES
IMOS
$1.89B
| $510K | ﹤0.01% |
21,548
+6,135
| +40% | +$154K |
|
2286
CTS Corp
CTS
$1.6B
| $510K | ﹤0.01% |
+11,971
| New | +$526K |
|
|
ICPT
2287
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $510K | ﹤0.01% |
46,100
-189,191
| -80% | -$2.64M |
|
2288
Belden
BDC
$4.56B
| $507K | ﹤0.01% |
5,300
-14,842
| -74% | -$1.27M |
|
2289
Madison Square Garden
MSGE
$3.77B
| $506K | ﹤0.01% |
+15,042
| New | +$516K |
|
|
AFMD
2290
DELISTED
Affimed
AFMD
| $503K | ﹤0.01% |
84,157
-5,915
| -7% | -$47.4K |
|
|
BRY
2291
DELISTED
Berry Corp
BRY
| $500K | ﹤0.01% |
72,718
-439,294
| -86% | -$3.17M |
|
2292
Viridian Therapeutics
VRDN
$2.72B
| $500K | ﹤0.01% |
+21,018
| New | +$539K |
|
2293
Rush Street Interactive
RSI
$3.05B
| $497K | ﹤0.01% |
159,256
+22,903
| +17% | +$70.7K |
|
2294
Cosan
CSAN
$2.64B
| $497K | ﹤0.01% |
33,300
| – | – |
|
2295
CleanSpark
CLSK
$3.06B
| $495K | ﹤0.01% |
115,501
-790,961
| -87% | -$3.18M |
|
2296
Kforce
KFRC
$1.03B
| $495K | ﹤0.01% |
7,900
| – | – |
|
2297
NETSCOUT
NTCT
$2.75B
| $495K | ﹤0.01% |
15,987
-12,107
| -43% | -$356K |
|
|
KRON
2298
DELISTED
Kronos Bio
KRON
| $494K | ﹤0.01% |
287,130
+125,488
| +78% | +$199K |
|
|
SPRB
2299
Spruce Biosciences
SPRB
$169M
| $490K | ﹤0.01% |
3,042
+866
| +40% | +$145K |
|
2300
ReNew
RNW
$2.48B
| $488K | ﹤0.01% |
89,100
| – | – |
|
Similar funds
John Overdeck's Q2 2023 Portfolio in Review
As of Q2 2023, John Overdeck held 3,452 positions worth $39.9B, up 14% from $35B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.
John Overdeck deployed $2.46B of net new capital in Q2 2023, opening 521 new positions and adding to 1,149 existing holdings. Its largest new stake was Nike: 2,150,643 shares worth $237M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Netflix, an estimated $238M trimmed.
- John Overdeck's largest Q2 2023 buy was Nike: 2,150,643 shares worth $237M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $332M increase.
- John Overdeck's biggest Q2 2023 reduction was Netflix, cutting an estimated $238M.
- John Overdeck fully exited Goldman Sachs in Q2 2023, selling an estimated $127M.
- John Overdeck's ten largest holdings make up 7.6% of its $39.9B portfolio in Q2 2023.
- John Overdeck opened 521 new positions and closed 479 in Q2 2023.
- John Overdeck's portfolio value rose 14% quarter-over-quarter to $39.9B.
Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.